CTI Life Sciences Fund - aVenture Asset Manager Research
Location
Montreal, Quebec, CA
Founded
2006
CTI Life Sciences Fund is a Canadian venture capital firm that specializes in start-up and seed stage investments, with a particular focus on the life sciences sector. The firm typically participates in Series A funding rounds, providing crucial early-stage capital to innovative companies in the biotechnology and pharmaceutical industries.
Notable portfolio companies include Somnus Therapeutics, which has raised $15 million, and XTuit Pharmaceuticals, which has raised $22 million. CTI Life Sciences Fund is known for its experienced team of key partners and decision-makers who bring a wealth of industry knowledge and strategic guidance to their portfolio companies. The firm also offers unique value-add services such as operational support and strategic partnerships to help their investments succeed.
CTI Life Sciences Fund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies3
Current Portfolio Count3
Top Investment Stages
Series A2 (66.7%)
Series B1 (33.3%)
Stage Mix
Series A 67%Series B 33%
Concentration shown as share of disclosed investments by stage.